Eminence Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Eminence Capital’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,426,210	Closed	-$34.4M	–	48
2017 Q2	$34.4M	Buy	+1,426,210	New	+$36.3M	0.59%	41

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Eminence Capital's SBRA Position: Q3 2017 in Review

Eminence Capital sold out of Sabra Healthcare REIT (SBRA) in Q3 2017, closing a stake of 1,426,210 shares — an estimated $34.4M sold.

Eminence Capital first reported a position in SBRA in Q2 2017 and held it in 1 quarter. The position peaked at $34.4M in Q2 2017. 337 funds tracked by Wall St. Rank hold SBRA as of Q3 2017.

Eminence Capital reported no remaining Sabra Healthcare REIT position as of Q3 2017 after selling out during the quarter.
Eminence Capital sold 1,426,210 Sabra Healthcare REIT shares in Q3 2017, an estimated $34.4M.
Eminence Capital first reported a position in Sabra Healthcare REIT in Q2 2017 and held it in 1 quarter.
Eminence Capital's Sabra Healthcare REIT position peaked at $34.4M in Q2 2017.
337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2017.

Based on Eminence Capital's 13F filing for Q3 2017, filed 14 Nov 2017.